Giancola Becomes CEO – Hobart and William Smith Colleges \
The HWS Update

Giancola Becomes CEO

Richard Giancola ’78 joined Neuromonics Inc., this summer as chief executive officer and member of its board of directors. Giancola has spent more than 25 years driving multi-million dollar sales growth for global medical device companies, most recently as vice president and general manager, Latin America, for Cochlear Americas.

“Rick has a proven track record of growing emerging markets for medical device treatments into multi-million dollar businesses,” said Ron West, chairman of Neuromonics.

Giancola spent nine years with Cochlear Americas, increasing the company’s sales to make it a multi-million dollar business. He has an extensive background in the medical device industry, including positions with American Hospital Supply and Deseret Medical. For 10 years, he has been president of Landmark Medical Exports, Inc., which he founded. The export management and consulting firm specializes in Latin America.

“I am pleased to be joining the company at this time of rapid growth and I look forward to furthering the company’s leadership in tinnitus research and treatment,” said Giancola.

Neuromonics is the manufacturer and distributor of a non-invasive FDA-cleared, patented medical device intended to provide long-term relief of tinnitus, a ringing or other noise in the ears. The Company released a clinical study just last month evaluating the device’s effectiveness.

Giancola graduated from Hobart College with a B.A. in psychology and was both a member of the lacrosse team and on the dean’s list. He was a member of the Sigma Chi fraternity and was also very active in the student court. After graduating from HWS, he continued his education at Syracuse University where he received his M.B.A in marketing in 1980.